ArticleAmerican journal of hematology2018

A phase I study of lenalidomide plus chemotherapy with mitoxantrone, etoposide, and cytarabine for the reinduction of patients with acute myeloid leukemia.

Daniel J DeAngelo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.